Breso

Medicinal product

(Invented) name

Breso

Active substance (s)

Mometazono furoatas

Strength

50 µg

Pharmaceutical form

nosies purškalas (suspensija)

Route (s) of administration

vartoti į nosį

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R01AD09, Mometasone

Marketing authorisation holder

UAB Actiofarma, Lietuva

Date of authorisation

2018-10-31

Date of renewal

Documents

0779_Breso_PZPL_2018-10-31.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Kiekvienoje išpurškiamoje dozėje yra	1 vnt.
Mometazono furoatas	50 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
100410	86519	1086519	buteliukas	140 dozių N1		Receptinis	LT/L/18/0779/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
	Išregistruotas
2018-10-31	Registruotas